Table 1.
Species | Source of inflammation | Impact of Blooms | References |
---|---|---|---|
Mucosa-associated symbiotic E. coli strains | Patients with inflammatory bowel disease | Monocolonization increased incidence of invasive carcinoma in the IL-10-deficient colorectal cancer mouse model | 27 |
Symbiotic E. coli | C. jejuni-colonized infant mice | Reduced colonization resistance against C. jejuni | 35 |
Enterobacterial species | Mouse oral C. rodentium infection | Unknown | 34 |
Proteobacterial species | Toll-like receptor 5-deficient mice | Transient instability of the gut microbiota | 28 |
Adherent and invasive E. coli (AIEC) | Ileitis in patients with Crohn’s disease | Unknown | 30 |
E. coli isolates with heightened virulence | Isolated from patients with Crohn’s disease or ulcerative colitis | In vitro, enhanced capability to activate NLRP3 inflammation and resistance to macrophage killing. | 42 |
Blooms of Klebsiella pneumoniae and Proteus mirabilis | T-bet−/− ×Rag2−/−ulcerative colitis (TRUC) mouse model | Oral infection with these strains elicited colitis in Rag2−/− and WT adult mice | 41 |
Salmonella and E. coli | Mouse oral Salmonella model | High densities of Salmonella and E. coli lead to horizontal gene transfer of the colicin-plasmid p2 from Salmonella to E. coli | 98 |
E. coli pathobiont | Ampicillin and neomycin-treated mice | Multidrug-resistant E. coli capable of inducing lethal NAIP5–NLRC4 inflammasome in systemic infection | 36 |
Enterobacterial species | Clindamycin-treated mice | Enhanced susceptibility to Clostridium difficile-induced colitis | 29 |
Abbrevations: C. jejuni, Campylobacter jejuni; E. coli, Escherichia coli; IL-10, interleukin-10; WT, wild type.